London, UKJun 2021
Antidote Technologies raised €19M in a funding round in Jun 2021. The company is based in London, UK. Investors in the round: LBO France, Merck Global Health Innovation Fund, Octopus Ventures and 1 other. Data as of Nov 2026.
Amount raised
€19M
€19,146,653
Native amount
23,200,000 USD
Stage
Other
Investors
4
Provenance & confidence
Low confidenceAmount
23,200,000 USD
ECB-at-date → €19M · rate 1.2117 on 2021-06-04
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Jun 2021
Round type
—
Amount (EUR)
€19M
Other rounds
same companyRelated news
- Antidote raises USD23m to scale digital patient engagement servicesprivateequitywire.co.uk · 2021-06